The Medication Access and Training Expansion (“MATE”) Act was signed into law on December 29, 2022. The Act applies to all “qualified practitioners” anticipating initial or renewal DEA registration on or after June 27, 2023. A qualified practitioner is someone licensed under state law to prescribe controlled substances (excluding veterinarians). As part of the DEA…
We are pleased to announce today that Chambers USA ranked Milligan Lawless, P.C. and 4 of our attorneys among the best in Arizona for 2023. Among Arizona law firms, Milligan Lawless achieved a Band 1 ranking, Chambers USA’s highest recognition, in the Healthcare practice area. Chambers USA is an annual ranking that assesses each law…
For the past few years, healthcare professionals have faced unprecedented challenges, which have been exacerbated by the COVID-19 pandemic. A recent survey revealed that one of the top drivers for nurses leaving their current positions was the emotional toll of the job.[1] Conditions such as understaffing can lead to additional stress for physicians and other…
Concurrent with the Covid-19 Public Health Emergency (“PHE”), the Arizona Health Care Cost Containment System (“AHCCCS”) modified requirements related to member enrollment and provider revalidation. Following the Consolidated Appropriations Act of December 2022, Medicaid is decreasing specific additional funding made available during the PHE. As a result, AHCCCS has returned to the regular renewal process…
In 2018, Governor Ducey signed the Arizona Opioid Epidemic Act, which set strict limits on opioid prescribing for physicians who practice in Arizona.[1] That legislation prohibited health care professionals from prescribing more than a five-day supply of opioids, with certain exceptions, e.g., patients with cancer pain, and patients in hospice. The legislation was the product…
Arizona passed a new law[1] clarifying that licensed health professionals can form and practice through different types of business entities.
The materials provided in this website are for informational purposes only and are not for the purpose of providing legal advice. Transmission of information from the ML website is not intended to create, and its receipt by you does not create an attorney-client relationship with ML or any of its individual attorneys or personnel.
If you elect to communicate with anyone at ML through this website, or otherwise, in connection with a matter for which we do not already represent you, your communication can not be treated as privileged or confidential. Do not transmit any information about any matter (and particularly not information you regard as confidential) that may involve you until ML has agreed to represent you, and you have received confirmation of that fact in the form of a written engagement letter.